Verrica Pharmaceuticals Inc. VRCA
3.19 USD 0.00 (+0.00%)
At closeNov 6, 2026, 4:00 PM EST
3.21 +0.02 +0.63%
After hours · Nov 6, 4:00 PM ET
Day range unavailable
3.08 52-week range 9.82
- YTD
- -61.61%
- 1 year
- -10.89%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 35.58M | 7.57M | 5.12M | 9.03M | 12.00M | |
| 32.14M | 4.83M | 4.38M | 8.31M | 12.00M | |
| -12.19M | -65.92M | -65.76M | -21.30M | -30.91M | |
| -17.89M | -76.58M | -67.00M | -24.49M | -35.08M | |
| -1.68 | -14.78 | -14.80 | -7.20 | -13.00 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 30.15M | 46.33M | 69.55M | 34.27M | 15.75M | |
| 47.13M | 54.13M | 81.60M | 44.72M | 80.13M | |
| 22.39M | 63.99M | 61.83M | 4.69M | 47.52M | |
| 1.63M | 45.94M | 45.51M | 1.53M | 43.41M | |
| 24.74M | -9.86M | 19.76M | 40.03M | 32.60M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -17.63M | -60.93M | -38.58M | -18.65M | -27.58M | |
| 1.45M | 37.73M | 74.21M | -16.87M | 33.65M | |
| -16.18M | -23.22M | 35.27M | 18.52M | 5.07M |